Imbalance between circulating CD4+ regulatory T and conventional T lymphocytes in patients with HBV-related acute-on-chronic liver failure

Liver Int. 2013 Nov;33(10):1517-26. doi: 10.1111/liv.12248. Epub 2013 Jul 21.

Abstract

Background & aims: The important pathophysiological role of immune dysfunction, especially innate immune dysfunction in patients with acute-on-chronic liver failure (ACLF), has been investigated in recent years, but dysregulation of adaptive immunity remains poorly elucidated. The aim of this study was to (i) determine the CD3(+) T-lymphocyte count and the balance between CD4(+) regulatory T (Tregs) and conventional T cells (Tconv) in hepatitis B virus (HBV)-related ACLF patients; (ii) analyse the frequencies of Tregs subpopulations; and (iii) assess the suppressive potency of CD4(+) Tregs and each fraction.

Methods: We enrolled 20 HBV-ACLF patients, 10 septic shock subjects, 20 chronic hepatitis B (CHB) patients and 20 healthy volunteers (HC). Based on flow cytometry, we performed the absolute counting of circulating T lymphocytes and phenotyping of CD4(+) Tregs and quantified the effects of Tregs and each subpopulation on Tconv proliferation by CFSE staining.

Results: Compared with CHB patients and HC, we observed an equal reduction in peripheral T subsets in HBV-ACLF and septic shock subjects; the number of CD4(+) Tregs remained unchanged and the Tconv count declined, promoting elevation of the Treg-to-Tconv ratio. The frequencies of Treg-II and -III were elevated in HBV-ACLF. Functional studies showed that the suppressive capacity of Tregs was preserved in the HBV-ACLF group and Treg-II came first.

Conclusions: Similar to septic shock subjects, in HBV-ACLF patients there exists a reduction in CD4(+) T lymphocytes, predominantly CD4(+) Tconv, and the development of suppressive CD4(+) Tregs greatly prevails over Tconv, constituting important characteristics of adaptive immune dysfunction of HBV-ACLF.

Keywords: CD3+ T cells; CD4+ regulatory T lymphocytes; HBV-related acute-on-chronic liver failure; chronic hepatitis B; conventional T lymphocytes; septic shock.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Analysis of Variance
  • China
  • End Stage Liver Disease / etiology*
  • End Stage Liver Disease / immunology*
  • Female
  • Flow Cytometry
  • Fluoresceins
  • Hepatitis B, Chronic / complications*
  • Humans
  • Immunophenotyping
  • Liver Failure, Acute / etiology*
  • Liver Failure, Acute / immunology*
  • Male
  • Middle Aged
  • Shock, Septic / immunology
  • Succinimides
  • T-Lymphocyte Subsets / immunology*
  • T-Lymphocytes, Regulatory / immunology*

Substances

  • 5-(6)-carboxyfluorescein diacetate succinimidyl ester
  • Fluoresceins
  • Succinimides